BioStock: PHI advances its IVF focus with HoloOocyte
Phase Holographic Imaging previously this year identified veterinary in vitro fertilization (IVF) as a new area of application through the HoloOocyte concept, where PHI is developing a specialized version of HoloMonitor for cattle and horses. CEO Patrik Eschricht tells BioStock about the ambitions to establish partnerships that can validate the solution and clarify the commercial need within veterinary IVF.
Read the full interview at biostock.se:
PHI takes the next step in the IVF initiative with HoloOocyte
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/